Ivana V. M.
- Country
- Germany
- Department
- Medizinischen Klinik II (Hämatologie/ Onkologie)
Research Overview
- Phase III Randomized Open‑Label Study of Cevostamab Combination Therapy Versus Standard of Care in Relapsed/Refractory Multiple Myeloma After 1‑3 Prior Lines
- Randomized phase II trial for patients with newly diagnosed low-risk multiple myeloma to evaluate the benefit of 6 cycles of isatuximab with lenalidomide/bortezomib/dexamethasone (I-VRD) followed by maintenance therapy with lenalidomide and isatuximab randomized in comparison with therapy consisting of 3 cycles of I-VRD followed by one cycle of high-dose therapy and maintenance therapy with lenalidomide and isatuximab
- Phase III Evaluation of Elotuzumab with Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Post-Autologous Stem Cell Transplant
Data & Insights
Has run more than one trial at 123 of 240 partner sites.
Specializations
Multiple Myeloma Treatment Innovation
The investigator specializes in developing advanced therapeutic approaches for multiple myeloma, with particular focus on newly diagnosed cases and treatment-resistant forms of the disease.
- Novel combination therapies
- Immunotherapy integration
- Treatment optimization strategies
Their work encompasses various therapeutic combinations including isatuximab, lenalidomide, and bortezomib based regimens.
Stem Cell Therapy Research
The investigator conducts extensive research in stem cell transplantation approaches, particularly focusing on both autologous and allogeneic transplantation methods for multiple myeloma treatment.
- Transplant eligibility assessment
- Post-transplant maintenance strategies
- Salvage therapy protocols
Their research includes evaluating maintenance therapy options following stem cell transplantation.
Treatment Response Assessment
The investigator specializes in evaluating treatment effectiveness through advanced monitoring methods, particularly focusing on minimal residual disease assessment.
- Flow cytometry analysis
- Response criteria development
- Progression monitoring
Their expertise includes tracking disease progression and treatment response using sophisticated diagnostic techniques.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.